← Back to Search

Other

Korean Red Ginseng for Cardiovascular Health

N/A
Recruiting
Led By Amir H.S. Rafie, MD
Research Sponsored by Korea Ginseng Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to swallow tablets whole
Healthy adults (male and female) who are 20 to 75 years of age (inclusive)
Must not have
Undergone major surgery in 3 months prior to screening or planned major surgery during the study
Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This trial aims to find out if the TP has any effect on blood flow and platelet aggregation, and if it is beneficial for cardiovascular health. It also wants to understand if the TP is safe and

Who is the study for?
This trial is for healthy adults interested in the potential cardiovascular benefits of Korean Red Ginseng. Participants should not have any current heart conditions or high blood pressure and must be willing to take either a placebo or ginseng tablets.Check my eligibility
What is being tested?
The study tests if Korean Red Ginseng Extract improves blood flow and reduces platelet aggregation compared to a placebo. It also examines its effects on overall cardiovascular health. There are two doses being tested: one with 120 mg/tablets and another with 500 mg/tablets.See study design
What are the potential side effects?
Possible side effects may include digestive discomfort, headaches, sleep problems, allergic reactions, or changes in blood pressure. However, as this trial is assessing safety too, exact side effects will be monitored closely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can swallow pills without any issues.
Select...
I am a healthy adult aged between 20 and 75.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not had major surgery in the last 3 months and do not plan any during the study.
Select...
I regularly take NSAIDs for pain or inflammation.
Select...
I cannot swallow or digest food properly due to a GI tract issue.
Select...
I have a history of immune, cancer, or psychiatric disorders.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Flow
Platelet Aggregation
Secondary outcome measures
Adverse Events
Augmentation Index
Blood Coagulation assessed by Activated Partial Thromboplastin Time (aPTT)
+52 more

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: G1899 Korean Red Ginseng Extract Powder 120 mg/tabletActive Control1 Intervention
480 mg of Korean Red Ginseng Extract powder per day for a total of 12 weeks.
Group II: G1899 Korean Red Ginseng Extract Powder 500 mg/tabletActive Control1 Intervention
2000 mg of Korean Red Ginseng Extract Powder per day for a total of 12 weeks.
Group III: PlaceboPlacebo Group1 Intervention
Inactive Ingredients

Find a Location

Who is running the clinical trial?

Korea Ginseng CorporationLead Sponsor
4 Previous Clinical Trials
1,536 Total Patients Enrolled
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK
34 Previous Clinical Trials
1,862 Total Patients Enrolled
Amir H.S. Rafie, MDPrincipal InvestigatorValiance Clinical Research
~0 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top